Publish in this journal
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Olga Sanchez-Pernautea,
Corresponding author
osanchez@fjd.es

Corresponding author.
, Fredeswinda I. Romero-Buenoa, Albert Selva-O’Callaghanb
a Rheumatology Division, Jiménez Díaz Foundation University Hospital and Health Research Institute, Universidad Autónoma de Madrid, Madrid, Spain
b Department of Internal Medicine, Hospital Universitari Val d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Read
1349
Times
was read the article
205
Total PDF
1027
Total HTML
117
Total EPUB
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2022 October 0 0 0 0
2022 September 67 24 13 104
2022 August 85 38 15 138
2022 July 72 43 15 130
2022 June 82 44 22 148
2022 May 81 40 48 169
2022 April 54 2 1 57
2022 March 56 2 1 59
2022 February 55 2 1 58
2022 January 220 2 0 222
2021 December 203 4 1 208
2021 November 52 4 0 56
2021 October 0 0 0 0
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?